Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.3M
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
26.9M
-
Shares change
-
-42.7K
-
Total reported value, excl. options
-
$187M
-
Value change
-
+$1.91M
-
Number of buys
-
48
-
Number of sells
-
-44
-
Price
-
$6.94
Significant Holders of ENZO BIOCHEM INC - Common Stock (ENZB) as of Q4 2016
118 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock as of Q4 2016.
ENZO BIOCHEM INC - Common Stock (ENZB) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.9M shares
of 52.3M outstanding shares and own 51.51% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4.25M shares), Evermore Global Advisors, LLC (3.31M shares), RENAISSANCE TECHNOLOGIES LLC (1.97M shares), DIMENSIONAL FUND ADVISORS LP (1.89M shares), BlackRock Institutional Trust Company, N.A. (1.53M shares), VANGUARD GROUP INC (1.53M shares), BlackRock Fund Advisors (1.28M shares), ACADIAN ASSET MANAGEMENT LLC (1.2M shares), First Light Asset Management, LLC (1.01M shares), and GILDER GAGNON HOWE & CO LLC (824K shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.